SEC Form 4 · accession 0001193125-26-402814
Beam Therapeutics Inc. · BEAM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Giuseppe Ciaramella
Officer — President
Period of report
Sep 24, 2026
Accepted (ET)
Sep 25, 2026 · 4:05 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001745999
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 24, 2026 | G | 123,407 | $0.00 | D | 130,504 | D | |
| Common StockF1 | holding | — | — | — | 123,407 | I | By spousal trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On September 24, 2026, the reporting person contributed 123,407 shares of BEAM common stock to the Giuseppe Ciaramella Irrevocable Trust - 2026, of which the reporting person's spouse is trustee. The beneficiaries of the trust are the reporting person's spouse and children. The reporting person disclaims beneficial ownership of the securities held by the trust.